Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChildren's Hospital of Philadelphia

About this trial

The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.

Eligibility criteria

Qualifiers

Self-identify as a current combustible tobacco user

Have a valid cell phone number

Must be a CHOP patient

Disqualifiers

<18 years in age.

Indicates no combustible tobacco smoking

Not a CHOP patient

Males or females ages ≥18 years in age

Trial design

Treatments tested in this trial

  • Refer2Quit

Treatment groups

3,200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital of Philadelphia

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Cancer Institute (NCI)

Collaborator